We are monitoring the impact of COVID-19 on Latin America Antifungal Drugs Market Get in touch with us for detailed analysis Know More
Share on

Latin America Antifungal Drugs Market Research Report – Segmented By Drug Type, Therapeutic Indications, Application & Country (Brazil, Mexico, Chile, Argentina and Rest of Latin America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 216
Pages: 145

Latin America Antifungal Drugs Market Size (2022 to 2027)

As per the report published, the Antifungal Drugs Market size in Latin America was worth USD 1.63 billion in 2022. It is further estimated to be growing at a CAGR of 3.8% and value USD 1.96 billion by 2027.

The demand for antifungal drugs in Latin America is mainly driven by increasing awareness of product availability through digital ads and campaigns. Furthermore, changes in environmental circumstances, an increase in the spread of numerous infectious diseases from person to person, and an increase in the number of fungal infections such as aspergillosis and candidiasis all contribute to the market's expansion in Latin America. In addition, the rise in health concerns and growing government and non-government support for antifungal diseases are expected to boost the Latin American market's growth rate over the forecast period.

Adopting the most up-to-date technologies in various pharmaceuticals and providing effective treatment procedures for various infectious diseases across the continent would help the market develop. In addition, the market is experiencing a surge in demand as people seek to boost their safety levels. Additionally, increased investments in research and development institutes are expected to help the market grow.

The release of COVID-19 has caused the market for antifungal medications in Latin America to rise faster. Interferons (IFNs) were discovered in tiny levels in the blood and lungs of patients with serious COVID-19. As a prospective aerosol therapy for COVID-19 patients, a powerful and safe medication combination of isotretinoin and antifungal medicines can be used. As a result of the COVID-19's favorable impact, the Latin American antifungal medications market is predicted to reach new heights over the forecast period.

The availability of alternative replacements is stifling the market for antifungal medications in Latin America. Long-term usage of these treatments has increased adverse effects, which has posed a challenge to market expansion. In addition, changes throughout drug production rates are slowly reducing the demand for antifungal drugs in Latin America. The market's growth rate is further hampered by a scarcity of competent workers in the medication manufacturing industry. The government's strict norms and procedures for approving the new pharmaceuticals further limit the market's growth. Antifungal medications can produce significant side effects such as liver damage and heart failure.

This research report on the Latin American antifungal drugs market has been segmented and sub-segmented into the following categories:

By Drug Type: 

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

By Therapeutic Indications: 

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

By Application: 

  • Powders
  • Ointments
  • Drugs
  • Pastes

By Country: 

  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the antifungal drugs market in Latin America is the second fast-growing market following Asia-Pacific. An increase in Health expenditure is the primary driver for the market in the region. Rising awareness of fungal diseases, an increase in the prevalence of antifungal illnesses, and increased government and corporate financing in the industry are the primary factors driving the Latin American market. Furthermore, the growing use of over-the-counter antifungal medications for cutaneous infections and an increase in public-private collaborations in the pharmaceutical business are primarily responsible for the market's growth. The market will also be driven by a rise in the population of weak people and have a higher rate of fungal infections than the average.

The market for antifungal medications in Latin America is being held back by the current high penetration of traditional drugs to treat fungal infections. Developing a variety of high-quality, low-cost pharmaceuticals is fueling this region's market growth rate.

Brazil is predicted to dominate the Latin American Antifungal Drugs market during the forecast period. It is expected to increase at a spectacular rate in the following years. A rise in the number of infectious disease cases in rural areas due to poor sanitation is a primary factor driving the market's growth.

Following Brazil, Mexico is expected to account for a significant portion of the Latin American antifungal drug industry. Increased financing from commercial and public bodies to study quality treatment practices has boosted the market for antifungal drugs in Mexico.

KEY MARKET PLAYERS:

Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Aspergillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead, and Abbott Laboratories are playing a dominant role in the Latin American Antifungal Drugs Market.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Echinocandins

                                5.1.2 Azoles

                                5.1.3 Polyenes

                                5.1.4 Allylamines

                                5.1.5 Others

                5.2 By Therapeutic Indications   

                                5.2.1 Aspergillosis

                                5.2.2 Dermatophytosis

                                5.2.3 Candidiasis

                                5.2.4 Others

                5.3 By Application           

                                5.3.1 Powders

                                5.3.2 Ointments

                                5.3.5 Drugs

                                5.3.4 Pastes

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 Brazil

                                6.3 Argentina

                                6.4 Mexico

                                6.5 Rest of Latin America

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Alternaria    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Pfizer            

                8.3 Novartis       

                8.4 Sanofi-Aventis          

                8.5 Merck & Co.               

                8.6 Asperqillus  

                8.7 Kramer Laboratories               

                8.8 Bayer Healthcare     

                8.9 Enzon Pharmaceuticals          

                8.10 Glaxosmithkline Gilead       

                8.11 Abbott Laboratories             

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  1. Latin America Antifungal Drugs Market, By Region, From 2022 - 2027 (USD Million)
  2. Latin America Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  3. Latin America Echinocandins Market, By Region, From 2022 - 2027 (USD Million)
  4. Latin America Azoles Market, By Region, From 2022 - 2027 (USD Million)
  5. Latin America Polyenes Market, By Region, From 2022 - 2027 (USD Million)
  6. Latin America Allylamines Market, By Region, From 2022 - 2027 (USD Million)
  7. Latin America Other Drugs Market, By Region, From 2022 - 2027 (USD Million)
  8. Latin America Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  9. Latin America Aspergillosis Market, By Region, From 2022 - 2027 (USD Million)
  10. Latin America Dermatophytosis Market, By Region, From 2022 - 2027 (USD Million)
  11. Latin America Candidiasis Market, By Region, From 2022 - 2027 (USD Million)
  12. Latin America Other Therapeutic Indications Market, By Region, From 2022 - 2027 (USD Million)
  13. Latin America Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  14. Latin America Powders Market, By Region, From 2022 - 2027 (USD Million)
  15. Latin America Ointments Market, By Region, From 2022 - 2027 (USD Million)
  16. Latin America Drugs Market, By Region, From 2022 - 2027 (USD Million)
  17. Latin America Pastes Market, By Region, From 2022 - 2027 (USD Million)
  18. Brazil Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  19. Brazil Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  20. Brazil Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  21. Argentina Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  22. Argentina Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  23. Argentina Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  24. Mexico Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  25. Mexico Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  26. Mexico Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)
  27. Rest of Latin America Antifungal Drugs Market, By Drug Type, From 2022 - 2027 (USD Million)
  28. Rest of Latin America Antifungal Drugs Market, By Therapeutic Indications, From 2022 - 2027 (USD Million)
  29. Rest of Latin America Antifungal Drugs Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample